Opko Health (OPK) Divestments (2010 - 2026)

Opko Health's (OPK) quarterly Divestments came in at $18.4 million in Q2 2026, down 91.25% on a QoQ basis from $210.4 million in Q3 2024.

Opko Health (OPK) Divestments (2010 - 2026) Analysis & Trends

Opko Health (OPK) has 4 years of Divestments data on file, last reported at $18.4 million in Q2 2026.

  • Quarterly Divestments changed N/A year-over-year to $18.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $228.8 million (changed N/A YoY) and the FY2025 annual result came in at $197.8 million, down 5.99% from the prior year.
  • Divestments retreated to $18.4 million in Q2 2026, from $210.4 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $210.4 million in Q3 2024 to a low of -$115.4 million in Q4 2022.
  • A 3-year average of $37.8 million and a median of $18.4 million in 2026 frame the typical range for Divestments.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn -
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn -
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn -
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn -
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn -
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn -
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -
10 Opko Health 1.02 Bn 718.85 Mn 80.02 Mn 18.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 18.40 Mn
Sep 30, 2024 210.38 Mn
Dec 31, 2022 -115.42 Mn
Dec 31, 2010 -4,000.00